{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T11:15:08Z","timestamp":1775819708835,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.brachy.2015.01.002","type":"journal-article","created":{"date-parts":[[2015,2,26]],"date-time":"2015-02-26T11:01:41Z","timestamp":1424948501000},"page":"342-349","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Salvage low-dose-rate permanent seed brachytherapy for locally recurrent prostate cancer: Association between dose and late toxicity"],"prefix":"10.1016","volume":"14","author":[{"given":"Jim N.","family":"Rose","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juanita M.","family":"Crook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2040-4630","authenticated-orcid":false,"given":"Tom","family":"Pickles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mira","family":"Keyes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4551-5924","authenticated-orcid":false,"given":"W. James","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2015.01.002_bib1","doi-asserted-by":"crossref","first-page":"e363","DOI":"10.1016\/j.ijrobp.2011.12.070","article-title":"Clinical outcome of patients treated with 3D conformal radiation therapy 3D-CRT for prostate cancer on RTOG 9406","volume":"83","author":"Michalski","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2015.01.002_bib2","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/cncr.24020","article-title":"Twenty-four-month postradiation prostate biopsies are strongly predictive of 7-year disease-free survival","volume":"115","author":"Crook","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.brachy.2015.01.002_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.radonc.2005.06.002","article-title":"A phase II study of localized prostate cancer treated to 75.6 Gy with 3D conformal radiotherapy","volume":"76","author":"Nichol","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2015.01.002_bib4","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.urolonc.2013.12.014","article-title":"Underutilization of local salvage therapy after radiation therapy for prostate cancer","volume":"32","author":"Tran","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.brachy.2015.01.002_bib5","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1200\/JCO.2006.06.2497","article-title":"Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer","volume":"24","author":"Keating","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2015.01.002_bib6","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1002\/cncr.27911","article-title":"Population-based 10-year oncologic outcomes after low-dose-rate brachytherapy for low-risk and intermediate-risk prostate cancer","volume":"119","author":"Morris","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.brachy.2015.01.002_bib7","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1016\/j.juro.2006.07.075","article-title":"Salvage radical prostatectomy: Quality of life outcomes and long-term oncological control of radiorecurrent prostate cancer","volume":"176","author":"Sanderson","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.brachy.2015.01.002_bib8","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1097\/01.ju.0000155534.54711.60","article-title":"Salvage surgery for radiorecurrent prostate cancer: Contemporary outcomes","volume":"173","author":"Ward","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.brachy.2015.01.002_bib9","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1002\/cncr.22941","article-title":"Patient selection, cancer control, and complications after salvage local therapy for postradiation prostate-specific antigen failure: A systematic review of the literature","volume":"110","author":"Nguyen","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.brachy.2015.01.002_bib10","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1200\/JCO.2002.06.086","article-title":"Salvage cryotherapy for recurrent prostate cancer after radiotherapy: Variables affecting patient outcome","volume":"20","author":"Izawa","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2015.01.002_bib11","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3816\/CGC.2003.n.018","article-title":"Salvage cryosurgery for recurrent prostate cancer after radiation therapy: A seven-year follow-up","volume":"2","author":"Bahn","year":"2003","journal-title":"Clin Prostate Cancer"},{"key":"10.1016\/j.brachy.2015.01.002_bib12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.4111\/kju.2014.55.2.91","article-title":"High-focused ultrasound as salvage therapy for patients with recurrent prostate cancer after radiotherapy","volume":"55","author":"Song","year":"2014","journal-title":"Korean J Urol"},{"key":"10.1016\/j.brachy.2015.01.002_bib13","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0090-4295(98)00492-0","article-title":"Salvage brachytherapy for localized prostate cancer after radiotherapy failure","volume":"53","author":"Grado","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.brachy.2015.01.002_bib14","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.ijrobp.2009.06.061","article-title":"Long-term outcome and toxicity of salvage brachytherapy for local failure after initial radiotherapy for prostate cancer","volume":"77","author":"Burri","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2015.01.002_bib15","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ijrobp.2013.01.027","article-title":"Salvage HDR brachytherapy for recurrent prostate cancer after previous definitive radiation therapy: 5-Year outcomes","volume":"86","author":"Chen","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2015.01.002_bib16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.brachy.2013.10.012","article-title":"Salvage brachytherapy for recurrent prostate cancer","volume":"13","author":"Vargas","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2015.01.002_bib17","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.brachy.2013.11.005","article-title":"A Phase II study of salvage high-dose-rate brachytherapy for the treatment of locally recurrent prostate cancer after definitive external beam radiotherapy","volume":"13","author":"Yamada","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2015.01.002_bib18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.brachy.2009.06.007","article-title":"Treatment outcome and toxicity after salvage 125-I implantation for prostate recurrences after primary 125-I implantation and external beam radiotherapy","volume":"9","author":"Moman","year":"2010","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2015.01.002_bib19","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1016\/j.juro.2006.07.008","article-title":"Combined prostate brachytherapy and short-term androgen deprivation therapy as salvage therapy for locally recurrent prostate cancer after external beam irradiation","volume":"176","author":"Wong","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.brachy.2015.01.002_bib20","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1002\/cncr.22934","article-title":"Magnetic resonance image-guided salvage brachytherapy after radiation in select men who initially presented with favorable-risk prostate cancer: A prospective phase 2 study","volume":"110","author":"Nguyen","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.brachy.2015.01.002_bib21","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.eururo.2011.09.027","article-title":"Functional outcomes and complications following radiation therapy for prostate cancer: A critical analysis of the literature","volume":"61","author":"Bud\u00e4us","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.brachy.2015.01.002_bib22","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.ijrobp.2014.06.037","article-title":"Late urinary side effects 10 years after LDR prostate brachytherapy: Population-based results from a multi-physician practice treating with a standardized protocol and uniform dosimetric goals","volume":"90","author":"Keyes","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2015.01.002_bib23","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.brachy.2011.05.007","article-title":"Rectal toxicity and rectal dosimetry in low-dose-rate (125)I permanent prostate implants: A long-term study in 1006 patients","volume":"11","author":"Keyes","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2015.01.002_bib24","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.juro.2007.08.136","article-title":"Long-term urinary sequelae following 125Iodine prostate brachytherapy","volume":"79","author":"Crook","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.brachy.2015.01.002_bib25","doi-asserted-by":"crossref","first-page":"38.e1","DOI":"10.1016\/j.urolonc.2013.03.004","article-title":"Treatment outcomes and morbidity following definitive brachytherapy with or without external beam radiation for the treatment of localized prostate cancer: 20-Year experience at Mount Sinai Medical Center","volume":"32","author":"Marshall","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.brachy.2015.01.002_bib26","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ijrobp.2009.02.021","article-title":"Natural history of clinically staged low- and intermediate-risk prostate cancer treated with monotherapeutic permanent interstitial brachytherapy","volume":"76","author":"Taira","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2015.01.002_bib27","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.brachy.2013.08.006","article-title":"Whole prostate D90 and V100: A dose-response analysis of 2000 consecutive 125I monotherapy patients","volume":"13","author":"Morris","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2015.01.002_bib28","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ijrobp.2009.07.1723","article-title":"Biochemical disease free rate and toxicity for men treated with iodine-125 prostate brachytherapy with D90> 180 Gy","volume":"78","author":"G\u00f3mez-Iturriaga Pi\u00f1a","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2015.01.002_bib29","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijrobp.2007.06.067","article-title":"(125)I monotherapy using D90 implant doses of 180 Gy or greater","volume":"70","author":"Kao","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2015.01.002_bib30","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1464-410X.2009.08445.x","article-title":"Salvage permanent perineal radioactive-seed implantation for treating recurrence of localized prostate adenocarcinoma after external beam radiotherapy","volume":"104","author":"Aaronson","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.brachy.2015.01.002_bib31","unstructured":"RTOG 0526. A prospective phase II trial of transperineal ultrasound-guided brachytherapy for locally recurrent prostate adenocarcinoma following external beam radiotherapy. 2014. Available at: http:\/\/www.rtog.org\/ClinicalTrials\/ProtocolTable\/StudyDetails.aspx?study=0526. Accessed May 23,\u00a02014."},{"key":"10.1016\/j.brachy.2015.01.002_bib32","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1148\/radiol.09090475","article-title":"Prostate cancer: Value of multiparametric MR imaging at 3 T for detection\u2014Histopathological correlation","volume":"255","author":"Turkbey","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.brachy.2015.01.002_bib33","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0090-4295(99)00241-1","article-title":"Permanent brachytherapy as salvage treatment for recurrent prostate cancer","volume":"54","author":"Beyer","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.brachy.2015.01.002_bib34","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.brachy.2007.11.002","article-title":"Salvage prostate brachytherapy for localized prostate cancer failure after external beam radiation therapy","volume":"7","author":"Lee","year":"2008","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2015.01.002_bib35","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ijrobp.2012.04.028","article-title":"Feasibility of MR Imaging\/MR Spectroscopy-planned focal partial salvage permanent prostate implant (PPI) for localized recurrence after initial PPI for prostate cancer","volume":"85","author":"Hsu","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472115000045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472115000045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:08:32Z","timestamp":1761530912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472115000045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S1538472115000045"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2015.01.002","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Salvage low-dose-rate permanent seed brachytherapy for locally recurrent prostate cancer: Association between dose and late toxicity","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2015.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}